Swedish Orphan Biovitrum AB (publ) BIOVF Price Prediction

The determination to procure Swedish Orphan Biovitrum AB (publ) is entirely contingent on your individualistic risk tolerance. As you may discern, Swedish Orphan Biovitrum AB (publ)'s value has experienced a fall of 0% during the preceding 24 hours, and Swedish Orphan Biovitrum AB (publ) has incurred a growth of 5.86% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Swedish Orphan Biovitrum AB (publ) will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Swedish Orphan Biovitrum AB (publ) may potentially surge to $45.10 by the end of this year. Looking at Swedish Orphan Biovitrum AB (publ)'s prospects in a more extended five-year timeline, the stock could potentially growth to as much as $42.21. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Swedish Orphan Biovitrum AB (publ) forecast, the price of Swedish Orphan Biovitrum AB (publ) will fall by -0.38% over the next week and reach $35.12 by January 22, 2026.

Based on the our new experimental Swedish Orphan Biovitrum AB (publ) forecast, the price of Swedish Orphan Biovitrum AB (publ) will increase by 3.9% over the next month and reach $36.63 by February 14, 2026.

As per our most recent prediction on Swedish Orphan Biovitrum AB (publ)'s value in 2026, BIOVF is anticipated to fluctuate within the range of $35.02 and $45.10. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Swedish Orphan Biovitrum AB (publ) price forecast fails to consider sudden and extreme price fluctuations.

Swedish Orphan Biovitrum AB (publ)'s future appears to be on an upward trend, with an maximum price of $42.21 projected after a period of five years. Based on the Swedish Orphan Biovitrum AB (publ) forecast for 2031, Swedish Orphan Biovitrum AB (publ)'s value may potentially reach its highest peak of approximately $42.21, while its lowest peak is anticipated to be around $38.33.

Based on the our new experimental Swedish Orphan Biovitrum AB (publ) price prediction simulation, BIOVF’s value in 2026 expected to grow by 27.96% to $45.10 if the best happened. The price will be between $45.10 and $35.02 during 2026.

According to our latest experimental simulation for Swedish Orphan Biovitrum AB (publ) price prediction, BIOVF’s value could rise by 33.83% to $47.17 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $47.17 and $37.89 throughout the year.

Our new experimental Swedish Orphan Biovitrum AB (publ) price prediction model suggests that BIOVF’s value in 2028 could increase by 13.2% , reaching $39.90 in the best-case scenario. The price is expected to range between $39.90 and $30.15 during the year.

Based on our experimental forecast model, Swedish Orphan Biovitrum AB (publ)'s value may experience a 0.99% growth in 2029, potentially reaching $35.59 under optimal conditions. The predicted price range for 2029 lies between $35.59 and $30.24.

Using our new experimental simulation for Swedish Orphan Biovitrum AB (publ) price predictions, BIOVF’s value in 2030 is expected to rise by 16.41% , reaching $41.03 in the best scenario. The price is forecasted to range between $41.03 and $31.95 over the course of 2030.

Our experimental simulation indicates that Swedish Orphan Biovitrum AB (publ)’s price could grow by 19.74% in 2031, potentially hitting $42.21 under ideal conditions. The price will likely fluctuate between $42.21 and $38.33 during the year.

Based on the findings from our latest experimental Swedish Orphan Biovitrum AB (publ) price prediction, BIOVF could see a 39.61% rise in value, reaching $49.21 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $49.21 and $41.13 throughout the year.

According to our experimental Swedish Orphan Biovitrum AB (publ) price prediction, BIOVF’s value is anticipated to rise by 71.9% in 2033, with the highest potential price being $60.59. Throughout the year, BIOVF’s price could range from $60.59 and $49.32.

The results from our new Swedish Orphan Biovitrum AB (publ) price prediction simulation suggest that BIOVF may rise by 94.62% in 2034, potentially reaching $68.60 under the best circumstances. The predicted price range for the year is between $68.60 and $58.63.

Based on our experimental forecast for Swedish Orphan Biovitrum AB (publ)’s price, BIOVF could grow by 135.79% , with the value potentially hitting $83.11 in 2035. The expected price range for the year lies between $83.11 and $64.97.

Our recent Swedish Orphan Biovitrum AB (publ) price prediction simulation suggests that BIOVF’s value might rise by 212.85% in 2036, possibly reaching $110.28 if conditions are optimal. The expected price range for 2036 is between $110.28 and $79.44.

According to the experimental simulation, Swedish Orphan Biovitrum AB (publ)’s value could rise by 287.99% in 2037, with a high of $136.76 under favorable conditions. The price is expected to fall between $136.76 and $108.63 over the course of the year.